Abnormal mouth-movements and oral damage associated with L-DOPA treatment.
D000328:Adult; D000368:Aged; D004295:Dihydroxyphenylalanine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009912:Oral Manifestations; D010300:Parkinson Disease / Q000188:drug therapy*; D010301:Parkinson Disease, Postencephalitic / Q000188:drug therapy
D004295:Dihydroxyphenylalanine